Publicaciones en colaboración con investigadores/as de Hospital Universitario de Jaén (12)

2024

  1. Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study

    The Lancet Microbe, Vol. 5, Núm. 4, pp. e390-e399

2020

  1. Towards the elimination of hepatitis C: Implementation of reflex testing in Andalusia

    Revista Espanola de Enfermedades Digestivas, Vol. 112, Núm. 7, pp. 515-519

2019

  1. Association of Fluid Overload with Clinical Outcomes in Critically Ill Children with Bronchiolitis: Bronquiolitis en la Unidad de Cuidados Intensivos Pediátricos (BRUCIP) Study∗

    Pediatric Critical Care Medicine, Vol. 20, Núm. 3, pp. E130-E136

2017

  1. Prospective Multicentre Study on the Epidemiology and Current Therapeutic Management of Severe Bronchiolitis in Spain

    BioMed Research International, Vol. 2017

2016

  1. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

  2. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  3. Infection in the elderly patient. Consensus recommendations for management in the Emergency Department

    Revista Espanola de Geriatria y Gerontologia, Vol. 51, Núm. 2, pp. 120-121

2014

  1. Clinical and virological efficacy of etravirine plus two active nucleos(t)ide analogs in an heterogeneous HIV-infected population

    PLoS ONE, Vol. 9, Núm. 5

  2. Multicentre evaluation of glycated haemoglobin (HbA1c) of Roche Diagnostics in Andalusia

    Clinical Biochemistry, Vol. 47, Núm. 12, pp. 1108-1111

  3. The role of accessibility policies and other determinants of health care provision in the initial prognosis of malignant melanoma: A cross-sectional study

    Journal of the American Academy of Dermatology, Vol. 71, Núm. 3, pp. 507-515

2010

  1. Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 4, pp. 468-476

2008

  1. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313